John C. Goodman, PhD, senior fellow at the Independent Institute, discusses TrumpRx and its goals for patients’ OOP drug costs.
John C. Goodman, PhD
Advertisement
John C. Goodman, PhD, senior fellow at the Independent Institute and president of the Goodman Institute for Public Policy Research
Articles by John C. Goodman, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
PCVs Significantly Reduce Pneumococcal Meningitis in Children
2
FDA Enforces Stricter Vaccine Development, Linking COVID Vaccine to Pediatric Deaths
3
The Regimen: Pharmacists Bridging the Treatment Gap for Patients with OUD
4
TrumpRx Promising Direct-to-Consumer Drugs for Discounted Prices
5
